BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 9, 2013
View Archived Issues
Novel antibody-drug conjugate for drug-resistant blood cancer tested in preclinical studies
Read More
Gilead Sciences presents further clinical data on Stribild
Read More
Scripps Research Institute designs dual JNK3/LRRK2 inhibitor
Read More
Effective treatment of pancreatic ductal carcinoma xenografts with CBL-0137
Read More
Final results of the IMPACT trial of the TLR9 agonist MGN-1703 reported
Read More
Sanofi discovers novel FGFR inhibitors
Read More
DBV Technologies completes enrollment in VIPES study of peanut allergy
Read More
Researchers present phase II results for famitinib in nasopharyngeal carcinoma
Read More
Margetuximab well tolerated and active in phase I solid tumors trial
Read More
Secukinumab demonstrates superiority to Enbrel in head-to-head phase III study
Read More
Bayer begins phase III trial of BAY-94-9027 in children with hemophilia A
Read More
Novartis and Biological E to deliver typhoid and paratyphoid vaccines to developing world
Read More
Capricor and Nile Therapeutics sign merger agreement
Read More
Bayer discloses new FGFR inhibitors for cancer
Read More
Sanofi presents novel cannabinoid CB2 receptor ligands
Read More
Santaris Pharma licenses Locked Nucleic Acid technology to RaNA Therapeutics
Read More
Researchers in the U.K. patent new agents for bacterial infections
Read More
EMA accepts MAA for new insulin glargine biosimilar product
Read More
Oramed begins patient enrollment in phase IIa trial of ORMD-0801
Read More
La Jolla Pharmaceutical begins dosing in phase II trial of GCS-100 in chronic kidney disease
Read More
Scientists at Receptos synthesize novel GLP-1 receptor modulators
Read More
Phase II study of C. difficile vaccine initiated in Japan
Read More
GSK files supplemental NDAs for combination of dabrafenib and trametinib in metastatic melanoma
Read More
Novavax commences phase I trial of A(H7N9) influenza vaccine candidate
Read More
AstraZeneca enters oncology collaboration with Cambridge medical research institutions
Read More
FDA clears Signum Dermalogix's IND application for SIG-990 in rosacea
Read More